Systematic review reveals no link between systemic immune-inflammation index and incidence, indicating increased mortality risk in heart failure patients.
Key Points
No significant association between systemic immune-inflammation index and heart failure incidence was found, demonstrating a result that may influence patient assessment.
The pooled risk ratio for the impact of systemic immune-inflammation index on mortality in heart failure patients was 1.44, indicating a significant risk increase.
Systematic review and meta-analysis conducted using data from fifteen studies on heart failure patients, incorporating over 77,000 individuals.
Findings suggest that while systemic immune-inflammation index is a valuable biomarker for mortality risk, no concrete link to heart failure incidence was established.